Skip to main content

Joltid

Popular

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areasCAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ — Insilico Medicine ("Insilico" HKEX:3696), a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration agreement with…

Read the full release →

News provided by PR Newswire.